Findings provide proof-of-concept for AVSBs as a novel strategy to reduce arbovirus transmission by targeting viral replication within the mosquito vector, suggesting that AVSBs could complement existing arbovirus control measures.
Abstract
Dengue virus (DENV) and chikungunya virus (CHIKV) remain major global health threats, yet approved antiviral therapies are lacking. Antiviral sugar baits (AVSBs) represent a novel transmission-blocking strategy that exploits the natural sugar-feeding behaviour of mosquitoes to deliver antiviral compounds directly to the mosquito vector. In this study, we evaluated the antiviral efficacy of AVSBs containing JNJ-A07, β-D-N4-hydroxycytidine (NHC, EIDD-1931), molnupiravir (MPV), and 4′-fluorouridine (4′FlU) in Aedes aegypti mosquitoes. An ex vivo mosquito gut model was used to select antiviral concentrations and to assess the ability of 4′FlU to reach the mosquito midgut following sugar feeding. AVSBs were subsequently evaluated for their effects on mosquito attractiveness, longevity, fecundity, and fertility, as well as their ability to suppress DENV and CHIKV infection in vivo. 4′FlU potently inhibited CHIKV replication in ex vivo mosquito guts and retained antiviral activity following sugar-bait administration. None of the antiviral compounds affected mosquito attraction to the bait, while only modest and compound-specific effects on mosquito fitness were observed. AVSBs containing JNJ-A07 significantly reduced DENV infection and dissemination, whereas 4′FlU-containing AVSBs significantly reduced CHIKV infection and viral loads. In contrast, NHC- and MPV-containing AVSBs did not exhibit antiviral activity in vivo. Collectively, these findings provide proof-of-concept for AVSBs as a novel strategy to reduce arbovirus transmission by targeting viral replication within the mosquito vector, suggesting that AVSBs could complement existing arbovirus control measures.
Findings identify spirostane saponins as promising antiviral scaffolds as promising antiviral scaffolds and support their further development as broad-spectrum antiviral agents.
E. Jiménez-Posada, O. M. Mosquera-Martínez, Sara M. Robledo et al.· Drug development research (P...· 0 citations
The synthetic AMP A4S7 was investigated, which effectively inhibited DENV-2 RNA and protein expression and reduced viral progeny production at specified concentrations without exhibiting cytotoxicity in Vero cells, and found the α-helical structure of A4S7 was found to be crucial for its antiviral activity.
Ting-Chun Lin, Jeng-Wei Lu, Chia-Hsin Liu et al.· Antiviral Research· 0 citations
The molecular mechanisms by which multiple ZIKV proteins synergistically regulate pathogenic processes are summarized and the current research basis and response strategies for flavivirus ADE are reviewed, and unresolved scientific questions are outlined.
Aedes (Ae.) aegypti and Ae. albopictus are efficient vectors of medically important Old World alphaviruses including chikungunya virus. In contrast to the well-characterized responses to orthoflavivirus infections, antiviral defense against alphaviruses in Aedes mosquitoes remains comparatively underexplored. This revi...
Jie-Ong Yin, Y. Chan, Wenn-Chyau Lee et al.· Acta Tropica· 0 citations
This multi-epitope malaria TBV demonstrated predicted immunogenic potency without evidence of allergenicity or toxicity, suggesting its potential to limit the transmission of multidrug-resistant Plasmodium strains.
H. Al-Madhagi· Microbes & Immunity· 0 citations
Limited antiviral activity against dengue virus serotype 2 under the tested conditions is indicated and support further work using wider concentration ranges and fractionation of its bioactive constituents are supported.
Maulidia Fitri Rusfandi, T. H. Sucipto, R. Saputri et al.· JURNAL ILMU KEFARMASIAN INDO...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.